A large single-center prospective study to investigate the factors influencing the choice of breast-conserving surgery versus mastectomy in Chinese women with early breast cancer

医学 乳腺癌 乳房切除术 保乳手术 前瞻性队列研究 优势比 外科肿瘤学 逻辑回归 乳房外科 普通外科 妇科 内科学 癌症
作者
Zhensheng Li,Yunjiang Liu,Jing Zhang,Yue Li,Kaiye Du,Shuo Zhang,Huina Han,Jun Zhang
出处
期刊:World Journal of Surgical Oncology [BioMed Central]
卷期号:21 (1)
标识
DOI:10.1186/s12957-023-02924-y
摘要

Abstract Background Compared to mastectomy, breast-conserving surgery (BCS) provides the same survival rate and a higher quality of life for patients with early breast cancer (EBC). However, Chinese women with EBC are known to have a low BCS rate. A large prospective cohort study was conducted to investigate the factors influencing the choice of BCS in this population. Methods In 2017, all women with unilateral EBC and eligible for BCS at our institution were enrolled. Before surgery, the patient’s trust in the surgeon and her perceived strength of the surgeon’s recommendation of BCS were measured through an in-person interview and validated ad hoc questionnaire. Multivariate logistic regressions on BCS procedure vs. mastectomy were used to estimate the odds ratio (OR). Results One thousand one hundred thirty-six patients enrolled at analysis had an average age of 51.8 and tumor size of 2.4 cm. 19.9% of patients had BCS. The “ strong ” level of trust in the surgeon was significantly associated with BCS with an OR of 2.944 ( p <0.001) when compared to the “ average or under ” trust. The “ strong ” and “ moderate ” strengths in surgeon recommendation for BCS were also found to be significantly associated with the BCS procedure with ORs of 12.376 ( p <0.001) and 1.757 ( p =0.040), respectively, compared to the “ neutral or dissuaded ” strength. Conclusions Stronger trust in surgeons and BCS recommendation by surgeons are associated with a higher rate of BCS in Chinese women with EBC. Interventional trials are needed to confirm this finding.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
朝暮完成签到 ,获得积分10
1秒前
1秒前
2秒前
2秒前
4秒前
foolish发布了新的文献求助10
5秒前
5秒前
三十三完成签到,获得积分10
5秒前
耿双贵发布了新的文献求助10
6秒前
杨诗婕发布了新的文献求助10
7秒前
tsunami完成签到,获得积分20
7秒前
zyf完成签到,获得积分10
7秒前
小鱼仔完成签到,获得积分20
7秒前
阿牛哥完成签到,获得积分10
8秒前
我要发sci完成签到,获得积分10
8秒前
HanFeiZi完成签到 ,获得积分10
9秒前
量子星尘发布了新的文献求助10
10秒前
10秒前
烟雨别离发布了新的文献求助100
11秒前
banana完成签到,获得积分10
13秒前
13秒前
13秒前
Yu完成签到,获得积分10
14秒前
15秒前
余喆完成签到,获得积分10
15秒前
15秒前
SciGPT应助decade采纳,获得10
16秒前
张龙雨完成签到 ,获得积分10
17秒前
17秒前
张丹兰完成签到,获得积分10
18秒前
18秒前
18秒前
月儿发布了新的文献求助10
18秒前
oopsabc完成签到,获得积分10
18秒前
sytbb完成签到 ,获得积分10
18秒前
研友_VZG7GZ应助honghong1992采纳,获得10
19秒前
小星星完成签到,获得积分10
19秒前
糊涂的皮卡丘完成签到,获得积分10
19秒前
科研通AI5应助蓝风铃采纳,获得10
19秒前
吃肯德基发布了新的文献求助10
19秒前
高分求助中
Comprehensive Toxicology Fourth Edition 24000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
Handbook of Social and Emotional Learning 800
Risankizumab Versus Ustekinumab For Patients with Moderate to Severe Crohn's Disease: Results from the Phase 3B SEQUENCE Study 600
International Handbook of Earthquake & Engineering Seismology, Part B 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5146528
求助须知:如何正确求助?哪些是违规求助? 4343439
关于积分的说明 13526708
捐赠科研通 4184572
什么是DOI,文献DOI怎么找? 2294727
邀请新用户注册赠送积分活动 1295166
关于科研通互助平台的介绍 1238264